Triple‑negative breast cancer (TNBC) accounts for 10‑15% of all breast cancer cases.
TNBCs lack estrogen and progesterone receptors and express low levels of HER2, and …

Depression and anxiety are common comorbidities in breast cancer patients. Whether
depression and anxiety are associated with breast cancer progression or mortality is …

This article is the American Cancer Society's update on female breast cancer statistics in the
United States, including population‐based data on incidence, mortality, survival, and …

BACKGROUND The American Cancer Society (ACS), the Centers for Disease Control and
Prevention (CDC), the National Cancer Institute (NCI), and the North American Association …

Background The coronavirus disease 2019 (COVID-19) pandemic has disrupted breast
cancer control through short-term declines in screening and delays in diagnosis and …

Background Metastatic breast cancer (MBC) treatment has changed substantially over time,
but we do not know whether survival post-metastasis has improved at the population level …

Background Women and their health care providers need a reliable answer to this important
question: If a woman chooses to participate in regular mammography screening, then how …

This article is the American Cancer Society's biennial update on female breast cancer
statistics in the United States, including data on incidence, mortality, survival, and screening …

Importance Breast cancer screening examinations using digital breast tomosynthesis (DBT)
has been shown to be associated with decreased false-positive test results and increased …

Importance Breast cancer mortality in the US declined between 1975 and 2019. The
association of changes in metastatic breast cancer treatment with improved breast cancer …